EC Healthcare Reports Mixed Sales Performance
Company Announcements

EC Healthcare Reports Mixed Sales Performance

EC Healthcare (HK:2138) has released an update.

EC Healthcare reported a mixed sales performance for the six months ending September 2024, with an overall sales volume decrease of up to 4% year-on-year, impacted by a significant 49% drop in aesthetic medical and wellness services in Mainland China. However, the company saw a promising 12% increase in sales volume from other services, highlighting diverse growth opportunities amidst a challenging market environment.

For further insights into HK:2138 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App